Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Encompass Health (EHC)
NYSE:EHC
EHC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$73.68 - $104.55
Previous CloseN/A
Volume95.02K
Average Volume (3M)655.93K
Market Cap
$10.06B
Enterprise Value$12.82B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)22.4
Beta0.60
Next Earnings
Apr 23, 2025EPS Estimate
1.2Last Dividend Ex-Date
Jan 02, 2025Dividend Yield0.63%
Share Statistics
EPS (TTM)4.46
Shares Outstanding100,749,540
10 Day Avg. Volume731,779
30 Day Avg. Volume655,932
Standard Deviation0.09
R-Squared0.29
Alpha0.00198
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.96
Price to Cash Flow (P/CF)9.60
P/FCF Ratio21.30
Enterprise Value/Market Cap1.27
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit13.73
Enterprise Value/Ebitda11.41
Forecast
1Y Price Target
$117.80Price Target Upside17.93% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
---
Encompass Health News
PremiumCompany Announcements
Encompass Health Approves Executive Compensation Increases
PremiumCompany Announcements
Encompass Health: Strong Q4 2024 Performance and Positive 2025 Outlook
PremiumCompany Announcements
Encompass Health’s Earnings Call Highlights Robust Growth---
Bulls Say, Bears Say
Bulls Say
Earnings4Q results demonstrated broad-based strength with revenues up 13%, EBITDA up 14%, and adjusted EPS up 23%.
Growth StrategyEHC continues to invest in growth by adding beds and development projects, including fully pre-fabricated facilities.
Market PositionHigh earnings visibility is expected for EHC in 2025, driven by its market-leading inpatient rehabilitation business and current utilization trends.
Bears Say
Cost ManagementMargins are expected to decline due to higher corporate and startup costs.
Non-recurring ItemsSeveral non-recurring items and headwinds, such as favorable reserves adjustments and increased start-up costs, are affecting the forecast.
ValuationThe earnings outlook remains skewed to the upside with a reasonable valuation near 10x the 2026 EBITDA forecast.
---
Ownership Overview
1.47% Insiders
30.76% Mutual Funds
21.40% Other Institutional Investors
23.47% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EHC FAQ
What was Encompass Health’s price range in the past 12 months?
Encompass Health lowest stock price was $73.68 and its highest was $104.55 in the past 12 months.
What is Encompass Health’s market cap?
Encompass Health’s market cap is $10.06B.
When is Encompass Health’s upcoming earnings report date?
Encompass Health’s upcoming earnings report date is Apr 23, 2025 which is in 60 days.
How were Encompass Health’s earnings last quarter?
Encompass Health released its earnings results on Feb 06, 2025. The company reported $1.17 earnings per share for the quarter, beating the consensus estimate of $1.025 by $0.145.
Is Encompass Health overvalued?
According to Wall Street analysts Encompass Health’s price is currently Undervalued.
Does Encompass Health pay dividends?
Encompass Health pays a Thriceyearly dividend of $0.64 which represents an annual dividend yield of 0.63%. See more information on Encompass Health dividends here
What is Encompass Health’s EPS estimate?
Encompass Health’s EPS estimate is 1.2.
How many shares outstanding does Encompass Health have?
Encompass Health has 100,749,540 shares outstanding.
What happened to Encompass Health’s price movement after its last earnings report?
Encompass Health reported an EPS of $1.17 in its last earnings report, beating expectations of $1.025. Following the earnings report the stock price went up 1.278%.
Which hedge fund is a major shareholder of Encompass Health?
Currently, no hedge funds are holding shares in EHC
---
Encompass Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$117.80 (17.93% Upside)
$117.80 (17.93% Upside)
Blogger Sentiment
Bullish
EHC Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 5.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $495.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days <0.1%
Last 30 Days ▼ 1.2%
Last 30 Days ▼ 1.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.95%
12-Months-Change
Fundamentals
Return on Equity
24.56%
Trailing 12-Months
Asset Growth
7.08%
Trailing 12-Months
Company Description
Encompass Health
Encompass Health Corp. engages in providing post-acute healthcare services. It operates through the following segments: Inpatient Rehabilitation and Home Health & Hospice. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac & pulmonary conditions, brain & spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
---
EHC Company Deck
---
EHC Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance with significant growth in revenue, EBITDA, and Medicare Advantage discharges. However, challenges such as increased group medical costs and uncertain provider tax benefits present headwinds. The overall sentiment leans towards positive due to the robust financial metrics and strategic growth initiatives.Read More>---
EHC Stock 12 Month Forecast
Average Price Target
$117.80
▲(17.93% Upside)
Technical Analysis
Acadia Healthcare
―
Community Health
―
HCA Healthcare
―
Select Medical
―
Tenet Healthcare
―
Best Analysts Covering EHC
1 Year
1 Year Success Rate
28/31 ratings generated profit
1 Year Average Return
+26.68%
reiterated a buy rating 8 days ago
Copying David S Macdonald's trades and holding each position for 1 Year would result in 90.32% of your transactions generating a profit, with an average return of +26.68% per trade.
---